It was a randomized, parallel, stratified trial of 2,725 patients with AF who received percutaneous coronary revascularization with a stent.27The trial pitted two doses of DT with dabigatran 110 mg twice daily (n = 981) and 150 mg twice daily with P2Y12 inhibitor versus conventional TT with warfarin with P2Y12 inhibitor and aspirin (n = 981). This evidence concerns the gene P2RY12 and atrial fibrillation.